PaceMate Acquires Medtronic's Paceart Optima Cardiac Monitoring Platform to Expand Global Remote Diagnostics Leadership

Aug 28, 2024 18:00 CST Updated 18:00

Medtronic

Medical Device Manufacturer

PaceMate

Developer of Cardiac Data Management Platform

August 27,Cardiac Data Management and Remote Monitoring EnterprisesPaceMate Announces Acquisition of Medtronic Paceart Optima SystemPaceart Optima is an on-site cardiac workflow solution. The transaction amount was not disclosed.

This strategic move throughIncreaseNearly 1000 clinic locations globally,Significantly expands the global coverage of PaceMate services, further enhancing PaceMate's ability to provide the leading and most comprehensive cardiac remote monitoring solutions, continuing to solidify its position as the preferred partner for advanced cardiac data management.

Medtronic's Cardiac Rhythm Management (CRM) business and PaceMate intend to collaborate closely to ensure a seamless transition.

"After a comprehensive evaluation, we believe that PaceMate is the best organization to serve Paceart customers and their future cardiac data workflow needs."MedtronicSenior Vice PresidentAndCardiac Rhythm ManagementPresident Kweli P. Thompson, Ph.D."PaceMate provides a first-class cardiac data management solution and will offer excellent ongoing support to Paceart customers."

PaceMate offers an industry-leading, comprehensive end-to-end platform supporting various types of cardiac devices, including implantable devices, portable monitors, heart failure devices, and remote patient monitors. This is combined with a full suite of flexible solutions, including software, patient communications, and clinical service support.

PaceMate's flagship product, PaceMateLIVE™, is considered top-tier remote cardiac monitoring software, utilizing powerful EHR integration for seamless implementation, intuitive use, and intelligent patient prioritization. With a leading robust, research-grade dataset, healthcare organizations can access state-of-the-art tools to optimize clinic operations and leverage patient-centered data for groundbreaking research.

PaceMate's announcement stated that the acquisition of Medtronic's solutions complements its own products, positioning it at the forefront of global cardiac care; believing it can lead to better patient outcomes and global innovation.

"Our shared values, dedication to customer experience, and commitment to excellence in patient-centered cardiac solutions make this agreement a perfect fit."Tripp Higgins, CEO of PaceMateSaid, "Paceart customers will benefit from the transition of Paceart staff to ongoing support from PaceMate., as well as enhanced service delivery and innovation. We are excited to set a new standard in the market by combining the strengths of both technologies, providing unparalleled support and advancement."

· END ·

--Featured Recommendations--